The drivers of non-adherence to albuminuria testing guidelines and the clinical and economic impact of not identifying chronic kidney disease
Clinical Nephrology · 01.10.2023 · 100 (4) · 145-156
DOI: 10.5414/cn111106 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Nephrology, erschienen am 01.10.2023. Verfasst von Franziska Groehl und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Albuminuria, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Groehl, F., Garreta-Rufas, A., Meredith, K., Harris, J., Rossing, P., Hobbs, F. D. R., & Wanner, C. (2023). The drivers of non-adherence to albuminuria testing guidelines and the clinical and economic impact of not identifying chronic kidney disease. Clinical Nephrology, 100(4), 145-156. https://doi.org/10.5414/cn111106
Vancouver
Groehl F, Garreta-Rufas A, Meredith K, Harris J, Rossing P, Hobbs FDR, et al. The drivers of non-adherence to albuminuria testing guidelines and the clinical and economic impact of not identifying chronic kidney disease. Clinical Nephrology. 2023;100(4):145-156. doi:10.5414/cn111106
BibTeX
@article{Groehl2023,
author = {Groehl, Franziska and Garreta-Rufas, Antonio and Meredith, Kimberley and Harris, James and Rossing, Peter and Hobbs, F D Richard and Wanner, Christoph},
title = {The drivers of non-adherence to albuminuria testing guidelines and the clinical and economic impact of not identifying chronic kidney disease},
journal = {Clinical Nephrology},
year = {2023},
volume = {100},
number = {4},
pages = {145--156},
doi = {10.5414/cn111106}
}
EUVIMED